Maynard Um
-
-
-
-
-
-
-
Boston Scientific (BSX) PT Lowered to $74 at UBS as Shares Near 5-Year Lows
-
-
-
-
-
-
-
Medical device stocks tumble after HCA flags weak surgical volumes
-
-
-
-
-
-
-
Wolfe Research Downgrades Boston Scientific (BSX) to Peerperform
-
-
-
-
-
-
-
Piper Sandler on Boston Scientific (BSX): 'The current pullback an attractive entry point'
-
-
-
-
-
-
-
Nephron Upgrades Boston Scientific (BSX) to Buy
-
-
-
-
-
-
-
Boston Scientific (BSX) PT Lowered to $80 at BTIG
-
-
-
-
-
-
-
Piper Sandler on BSX and MDT Following KOL Call
-
435,844 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

